- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02028390
Overlaying a Visual Wound Trace Onto Its Thermal Image in a Wound Clinic
November 1, 2016 updated by: Wound Vision
Scout Overlay-Trace-On-Thermal Feature in a Wound Clinic Setting: A Prospective Study
The purpose of this study is to test and evaluate how well a medical imaging device that takes both visual and thermal pictures of wounds or body surface areas of interest can help collect added information about the wounds or body surface areas of interest in a wound clinic.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45242
- Integrative Center for Healing
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18 or greater, of either gender and of any ethnic background
- Able to tolerate position change(s) and turns for up to 10 minutes comfortably
Have an existing external wound or body surface area of interest:
- External wound or body surface area of interest must be in separate body locations (ex: one on the right heel, one on the left heel, and the other on the sacrum)
Have qualifying external wound or body surface area of interest:
- External wound or body surface area of interest that fits entirely within the field of view and does not wrap around a body edge
- No device or treatment will obscure the external wound or body surface area of interest
Exclusion Criteria:
- Neonatal and pediatric patients
- Pregnant women
- Cannot tolerate position changes for up to 10 minutes comfortably (per external wound site imaged)
- On therapies or treatments which cannot be safely suspended long enough to conduct an imaging session as determined by facility policy
- Have a wound dressing or medical device which cannot or should not be removed as determined by site investigator
- Have an external wound with excessive or heavy exudate that cannot be controlled during the imaging session. Excessive drainage can obscure external wound features.
If the patient has a complex external wound:
- The external wound wraps around a body edge or otherwise cannot be imaged entirely within the visual field of view.
- From visual assessment, the external wound edges are not definable and/or cannot be clearly distinguished from other conditions near external wound (E.g. breakdown or the deterioration of the surrounding body surfaces due to other conditions such as cancer or other types of ulcers makes determining the edge of the external wound impossible).
- Have not provided signed informed consent
- Non-English speaking
- Subjects in isolation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: subjects with external wounds
Subjects with external wounds or body surface areas of interest are imaged visually and thermally with the Scout to trace the wound's perimeter visually and measure thermal variation data as described in the primary outcomes, using the ImageReview software.
|
All images are taken after the wound has acclimated.
Other Names:
Trace is drawn by the study staff using the ImageReview software.
Study staff overlay the trace of the visual external wound's perimeter onto the corresponding thermal image of the external wound.
Study Staff select an unaffected reference area of an adjacent body surface.
Study staff select an adjacent tissue trace of the wound trace overlay
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pixel gradient of the thermal wound surface
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Pixel gradient of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Mean pixel value of the thermal wound surface
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Mean pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Mode pixel value of the thermal wound surface
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Mode pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits at the wound clinic for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Pixel gradient of the thermal unaffected area of body surface selected
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Pixel gradient of the the thermal unaffected area of body surface selected will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Highest pixel value of the thermal wound surface
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Highest pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Lowest pixel value of the thermal wound surface
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Lowest pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Comparison of adjacent tissue trace around the wound bed's surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit).
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Comparison of adjacent tissue trace around the wound bed's surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit), with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Comparison of wound surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit).
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Comparison of wound surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit), with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Wound surface's % relative temperature above, below, or equal to the unaffected reference area's temperature
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Wound surface's % relative temperature above, below, or equal to the unaffected reference area's relative temperature, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
|
Adjacent tissue trace's surface % relative temperature above, below, or equal to the unaffected reference area's temperature
Time Frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Adjacent tissue trace's surface's % relative temperature above, below, or equal to the unaffected reference area's relative temperature, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.
|
Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Aletha W. Tippett, M.D., Integrative Center for Healing
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
December 23, 2013
First Submitted That Met QC Criteria
January 3, 2014
First Posted (Estimate)
January 7, 2014
Study Record Updates
Last Update Posted (Estimate)
November 2, 2016
Last Update Submitted That Met QC Criteria
November 1, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WV13CL-0008 Revision 02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds and Injuries
-
Solventum US LLC3MWithdrawn
-
Centre Hospitalier Universitaire de NīmesCompletedWounds and Injuries, Hands | Wounds and Injuries, Wrists | Wounds and Injuries, Feet | Wounds and Injuries, AnklesFrance
-
Baskent UniversityNot yet recruitingOccupational Exposure | Needlestick Injuries | Sharps Injuries
-
National Center for Gastroentestinal and Liver...CompletedNeedlestick Injuries
-
Superior UniversityActive, not recruitingNeedle Stick InjuriesPakistan
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingWounds and Injuries / MortalityChina
-
Assaf-Harofeh Medical CenterUnknownInjuries and Wounds
-
Hospital Universiti Sains MalaysiaActive, not recruiting
Clinical Trials on Scout takes visual and thermal images of external wounds
-
Sheba Medical CenterCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLFundação para a Ciência e a TecnologiaRecruitingHealthy | Healthy AgingPortugal
-
University of California, San DiegoNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsNot yet recruitingCervical Cancer | Human Immunodeficiency Virus (HIV) | Human Papillomavirus (HPV) | Cervical Intraepithelial Neoplasia (CIN) | HPV Associated CancersBotswana
-
Imam Abdulrahman Bin Faisal UniversityCompletedDental Anxiety | Local AnaestheticSaudi Arabia
-
DL AnalyticsNational Cancer Institute (NCI); Basic Health InternationalRecruitingCervical Intraepithelial Neoplasia | Uterine Cervical Neoplasms | Human Papillomavirus (HPV) | Cervical CancersEl Salvador
-
Leiden University Medical CenterCanadian Institutes of Health Research (CIHR); AstraZeneca; National Cancer Institute... and other collaboratorsRecruitingEndometrial CancerNetherlands, Canada, France, United Kingdom